Givaudan | GIVN - Kapitał Własny I Rezerwy





Kapitał Własny I Rezerwy Zmiana Data
Air Liquide EUR 26.21B 1.7B 2025-12
Akzo Nobel EUR 4.88B 222M 2026-03
Anheuser-Busch USD 97.74B 6.32B 2025-12
Arkema EUR 6.96B 913.9M 2026-03
Associated British Foods GBP 11.06B 64M 2025-12
BASF EUR 33.2B 434M 2025-12
Bayer EUR 28.85B 2.9B 2026-03
Beiersdorf EUR 8.6B 133M 2025-12
British American Tobacco GBP 46.03B 1.14B 2025-12
Covestro EUR 7B 908M 2025-12
Croda International GBP 2.28B 53.3M 2024-12
Danone EUR 16.92B 1.56B 2025-12
Diageo GBP 11.6B 1.58B 2025-12
Fresenius EUR 19.77B 1.14B 2025-12
Fresenius Medical Care EUR 14.2B 13.95B 2026-03
Givaudan CHF 4.54B 430M 2025-12
Heineken EUR 20.61B 2.9B 2025-12
Henkel EUR 20.5B 459M 2025-12
International Flavors Fragrances USD 14.12B 34M 2026-03
Johnson Matthey GBP 2.1B 194M 2025-12
Kerry EUR 6.49B 27M 2024-12
Lonza CHF 9.13B 513M 2025-12
L'Oréal EUR 34.95B 3.78B 2025-12
Merck EUR 29.74B 1.15B 2026-03
Nestle CHF 32.81B 3.98B 2025-12
Pernod Ricard EUR 3.44B 12.78B 2025-12
Reckitt Benckiser GBP 6.7B 1.39B 2024-12
SGS CHF 877M 188M 2024-12
Sika AG CHF 6.66B 481.4M 2025-12
Solvay EUR 1.18B 161M 2026-03
Tate & Lyle GBP 1.6B 52M 2026-06
Umicore EUR 2.24B 195.4M 2025-12
Victrex GBP 361.9M 71.6M 2026-06